In our previous research, we found that the serum SGLT1 levels of diabetic patients were significantly higher than those of non-diabetic patients, which prompted us to examine the role of SGLT1 in DCM. This evidence concerns the gene SLC5A1 and familial dilated cardiomyopathy.